rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Michael D. Witzeman

VP & Chief Financial Officer

Company insider

Files Form 4 as: VP & Chief Financial Officer, Chemed.

In numbers

Trades disclosed
124
Buys
0
Sells
14
Bought
$0
Sold
$10.2M
Companies
1
Companies where not an officer
0
First trade
22 May 2017
Last trade
20 Oct 2026
Last filed
22 Oct 2026

Companies traded

Where they are an officer
CHE ChemedOfficer · Providers & Facilities · last 20 Oct 20260 buys · 14 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
20 Oct 2026filed 22 Oct 2026CHE Chemedoption or derivative · Providers & FacilitiesSEC FORM 4 Code A$6.5M12,686 at $512.64filing
13 Feb 2026filed 17 Feb 2026CHE ChemedProviders & FacilitiesSEC FORM 4 Code M$194K413 at $469.56filing
13 Feb 2026filed 17 Feb 2026CHE ChemedProviders & FacilitiesSEC FORM 4 Code M—0 at $469.56filing
13 Feb 2026filed 17 Feb 2026CHE ChemedProviders & FacilitiesSEC FORM 4 Code F$56K120 at $469.56filing
13 Feb 2026filed 17 Feb 2026CHE Chemedoption or derivative · Providers & FacilitiesSEC FORM 4 Code M—333 at $0.00filing
13 Feb 2026filed 17 Feb 2026CHE Chemedoption or derivative · Providers & FacilitiesSEC FORM 4 Code M—333 at $0.00filing
13 Feb 2026filed 17 Feb 2026CHE Chemedoption or derivative · Providers & FacilitiesSEC FORM 4 Code A—1,394 at $0.00filing
13 Feb 2026filed 17 Feb 2026CHE Chemedoption or derivative · Providers & FacilitiesSEC FORM 4 Code M—333 at $0.00filing
13 Feb 2026filed 17 Feb 2026CHE Chemedoption or derivative · Providers & FacilitiesSEC FORM 4 Code M—333 at $0.00filing
13 Feb 2026filed 17 Feb 2026CHE Chemedoption or derivative · Providers & FacilitiesSEC FORM 4 Code A—1,394 at $0.00filing
13 Feb 2026filed 17 Feb 2026CHE ChemedProviders & FacilitiesSEC FORM 4 Code M$194K413 at $469.56filing
13 Feb 2026filed 17 Feb 2026CHE ChemedProviders & FacilitiesSEC FORM 4 Code M—0 at $469.56filing
13 Feb 2026filed 17 Feb 2026CHE ChemedProviders & FacilitiesSEC FORM 4 Code F$56K120 at $469.56filing
21 Oct 2025filed 22 Oct 2025CHE Chemedoption or derivative · Providers & FacilitiesSEC FORM 4 Code A$8.6M19,486 at $443.79filing
10 Mar 2025filed 11 Mar 2025CHE Chemedoption or derivative · Providers & FacilitiesSEC FORM 4 Code M$3.9M8,796 at $445.35filing
10 Mar 2025filed 11 Mar 2025CHE ChemedProviders & FacilitiesSEC FORM 4 Code M$3.9M8,796 at $445.35filing
10 Mar 2025filed 11 Mar 2025CHE ChemedProviders & FacilitiesSEC FORM 4 Code F$4.5M7,494 at $600.92filing
14 Feb 2025filed 18 Feb 2025CHE Chemedoption or derivative · Providers & FacilitiesSEC FORM 4 Code M—323 at $0.00filing
14 Feb 2025filed 18 Feb 2025CHE Chemedoption or derivative · Providers & FacilitiesSEC FORM 4 Code M—323 at $0.00filing
14 Feb 2025filed 18 Feb 2025CHE Chemedoption or derivative · Providers & FacilitiesSEC FORM 4 Code A—1,128 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care14

Buys in green, sells in red, by the company’s sector.

Related people

Thomas C. Huttonvice president · vice president at Chemed, filing Form 4 there in the last year
Spencer S. Leeexecutive vice president · executive vice president at Chemed, filing Form 4 there in the last year
Kevin J. McNamarapresident and CEO · president and CEO at Chemed, filing Form 4 there in the last year
Brian C. JudkinsVP and Chief Legal Officer · VP and Chief Legal Officer at Chemed, filing Form 4 there in the last year
Joel L. WherleyCEO - Vitas Healthcare · CEO - Vitas Healthcare at Chemed, filing Form 4 there in the last year
Patrick P. GraceDirector · Also traded CHE in the last 90 days